Y-Intercept (HK)
RLAY icon

Y-Intercept (HK)’s Relay Therapeutics RLAY Stock Holding History

Y-Intercept (HK)’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$218K Buy
+12,083
New +$231K ﹤0.01% 1471
2026
Q2 		– Sell
-17,516
Closed -$174K – 2092
2026
Q1 		$174K Buy
+17,516
New +$157K ﹤0.01% 1446
2024
Q4 		– Sell
-51,856
Closed -$367K – 1582
2024
Q3 		$367K Buy
+51,856
New +$387K 0.02% 927

Other funds holding RLAY

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Valeo Financial Advisors
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Quadrant Capital Group
Quadrant Capital Group Cincinnati, Ohio $3.7B AUM 33.76% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Y-Intercept (HK)'s RLAY Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Relay Therapeutics (RLAY) in Q3 2026: 12,083 shares worth $218K. The stake represents ﹤0.01% of the portfolio and ranks #1471 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in RLAY as recently as Q1 2026.

Y-Intercept (HK) first reported a position in RLAY in Q3 2024 and has held it in 3 quarters since. The position peaked at $367K in Q3 2024. 20 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • Y-Intercept (HK) held 12,083 shares of Relay Therapeutics worth $218K as of Q3 2026.
  • Relay Therapeutics was a new Y-Intercept (HK) position in Q3 2026.
  • Relay Therapeutics made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1471 holding.
  • Y-Intercept (HK) first reported a position in Relay Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • Y-Intercept (HK)'s Relay Therapeutics position peaked at $367K in Q3 2024.
  • 20 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.